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Lipid droplets (LDs) hypertrophy in adipocytes is the main cause of energy metabolic system dysfunction,
obesity and its afflictions such as T2D.However, the role of adipocytes in linking energymetabolic disorders
with insulin regulation is unknown in humans. Human adipocytes constitutively synthesize and secrete
insulin, which is biologically functional. Insulin concentrations and release are fat mass- and
LDs-dependent respectively. Fat reduction mediated by bariatric surgery repairs obesity-associated T2D.
The expression of genes, like PCSK1 (proinsulin conversion enzyme), GCG (Glucagon), GPLD1, CD38 and
NNAT, involved in insulin regulation/release were differentially expressed in pancreas and adipose tissue
(AT). INS (insulin) and GCG expression reduced in human AT-T2D as compared to AT-control, but
remained unchanged in pancreas in either state. Insulin levels (mRNA/protein) were higher in AT derived
from prediabetes BB rats with destructed pancreatic b-cells and controls than pancreas derived from the
same rats respectively. Insulin expression in 10 human primary cell types including adipocytes and
macrophages is an evidence for extrapancreatic insulin-producing cells. The data suggest a crosstalk
between AT and pancreas to fine-tune energy metabolic system or may minimize the metabolic damage
during diabetes. This study opens new avenues towards T2D therapy with a great impact on public health.
I
n 1922, Banting andMacleod discovered insulin expression in highly specialized endocrine b-cells within islets
of Langerhans in the pancreas1. On the one hand, insulin secretion is known to be affected by immunoreacti-
vity to insulin in type 1 diabetes (T1D) in humans. On the other hand, a second defect essential for develop-
ment from insulin resistance (IR) to type 2 diabetes (T2D) is the inability of endocrinal pancreatic b-cells to
produce the required levels of insulin that maintain normal blood glucose levels. It has also been shown that the
insulin sensitivity decreases in an obesity state and thereby suppresses b-cells functionality2,3. In addition, obesity
is implicated in multiple pathophysiological complications such as T2D and cardiovascular disease (CVD)4–6.
Since obesity is determined by the excessive mass of adipose tissue (AT) and in particular adipocytes, adipocytes
play an important role in the development of obesity7,8. Hypertrophy of adipocytes is the main cause of obesity7–9.
These results from the excessive storage of energy in the form of triglycerides (TGs) in lipid droplets (amonolayer
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membrane with a structure similar to very low-density lipoprotein10)
within adipocytes, which links to obesity and to IR. Of note, AT is
considered as the largest endocrine organ in humans7–9,11.
In spite of increasing studies on the properties of AT and in par-
ticular adipocytes, the mechanisms that lead to obesity-induced
pathophysiological states are still poorly understood. Moreover,
the advent of new technology that allows the characterization of
entire transcriptomes and proteomes12 had also led to the hope that
the properties of AT might be revealed to help discover new thera-
peutic avenues. However, hitherto, the results have not lived up to
their expected promises, prompting us to perform a well-designed
and in-depth study on human primary subcutaneous and visceral
preadipocytes and adipocytes.
Since AT is composed of different cell types13, the consequent
cross-talk could hamper a transparent view of human adipocytes.
Hence, we chose to study human primary adipocytes alone to avoid
AT complexity and obtain a clear detailed picture of human adipo-
cytes and its link with obesity and insulin regulation.
Results
Human primary preadipocytes were differentiated into adipocytes
and the pure adipocyte fractions were assessed by monitoring mor-
phologically and via lipid droplet labeling (Figure 1 A–B). The effi-
cacy of differentiation reached approximately 90–95%, indicating
that adipocytes could be considered as a specific homogenous cell
type. As depicted in Figure 1 A, no lipid droplet was observed and/or
detected in human preadipocytes. On the contrary, human adipo-
cytes were occupied by either medium-sized or single large lipid
droplets (Figure 1 B).
To confirm our microscopy approach to assess adipocyte-fraction
purity, the expression of five known mRNA markers for human
adipocytes and one for preadipocytes were measured. mRNA
expression displayed a significant up-regulation of the five mRNA
markers in both visceral and subcutaneous adipocytes, i.e. DGAT2,
LEP, LIPE, LPL and FSP27 (Figure 1 C–D) as compared to human
preadipocytes, and AEBP-1 was significantly up-regulated in both
human preadipocytes as compared to human adipocytes (Figure 1
E).
We investigated whether human primary subcutaneous and vis-
ceral (preadipocytes and adipocytes) cells express insulin (INS)
mRNA and, in turn, translated to insulin protein. All four tested cell
types expressed insulin mRNA as determined by mRNA expression-
arrays (Figure 2 A–B). As positive control and validation of obtained
results by human preadipocytes/adipocytes, we have measured the
INS (b-cells) and glucagon (GCG) (a-cells) mRNAs in human pan-
creas and AT. The relative intensity of INS and GCG mRNAs in
pancreas tissue reached saturated state. INS mRNA expression in
human pancreas was approximately 256-fold and 1100-fold higher
than INS mRNA expression in human AT-control and AT-T2D
respectively, but comparable with human pancreas derived from
human subject with T2D (Figure 2 C). Importantly, INS mRNA
expression was reduced in human AT-T2D as compared to the
AT-control (Figure 2 C). Of note, INSmRNA was expressed in both
ATs (Figure 2 C). As shown in figure 2 C, GCG expression was
completely diminished in AT-T2D as compared to AT-control.
GCG mRNA expression was also reduced by approximately 3-fold
in pancreas with T2D comparing with pancreas control tissue. To
determine the specificity of INS gene expression, we also measured
IGF1 and IGF2 expression in pancreas and AT in either state. The
expression of these three genes was completely different in pancreas
and AT in both control and T2D states (Figure 1, SI).
To determine whether the INS mRNA is translated into protein,
immunofluorescent confocal laser scanning microscopy (IFCLSM)
was applied to human subcutaneous and visceral (preadipocytes and
adipocytes) cells. Indeed, IFCLSM analysis revealed the huge insulin
protein staining in the cytoplasm and on the plasma membranes of
human visceral adipocytes (Figure 3 A–F) and subcutaneous adipo-
cytes (Figure 2 A–G, SI), while insulin protein expression in both
human visceral (Figure 4 A–E) and subcutaneous (Figure 3 A–G, SI)
preadipocytes were traces. IgG1 isotype controls were all negative
(preadipocytes and adipocytes) (Figure 3 A and 4 A). To validate
our findings that human adipocytes express insulin, immunoelectron
microscopy (IEM) was also applied to the primary visceral adipo-
cytes. As expected, IEM analysis (Figure 4B, SI) showed insulin pro-
tein expression in human adipocytes (conjugated with 15 nm gold
particles and visualized as black dots) similar to IFCLSM observations
(Figure 3 C). IgG1 isotype control was also negative (Figure 4 A, SI).
To investigate, whether insulin is secreted from human primary
subcutaneous and visceral cells, insulin protein levels were measured
in the media containing the secretion from all four cell types, using
DAKO Insulin ELISA KIT. As depicted in figure 5 A–B, insulin
protein was detected in the media of human primary visceral
(379 pmol/l) (Figure 5 A) and subcutaneous (55 pmol/l) (Figure 5
B) adipocytes. Notably, no insulin protein was detected in both
human primary preadipocytes (Figure 5 A–B).
To further establish the link between fatmass and insulin secretion
levels, we chose to stimulate all four cell types with LPS (200 ng/ml)
and 25 mM glucose. Upon LPS treatment, insulin protein levels
secreted by human subcutaneous and visceral adipocytes were
reduced approximately three-fold (Figure 5 A–B). Treatment of
human primary visceral adipocytes with glucose resulted in an
approximately four-fold less insulin protein concentrations than
the control (untreated with glucose) (Figure 5 A).
To determine, whether the lack of undetectable insulin secretion is
a specific feature of human preadipocytes, IL-6, IL-8 and M-CSF
protein concentrations were measured in the secretion of only
human subcutaneous preadipocytes treated with and without LPS.
IL-6, IL-8 and M-CSF proteins were notably detected and measured
in the secretion of human subcutaneous preadipocytes without LPS
treatment (2.5 pg/ml), (0.0 pg/ml) and (10.5 pg/ml) and treated
with LPS (499 pg/ml), (3610 pg/ml) and (97.7 pg/ml) respectively
(Figure 5 C).
To gain more knowledge about insulin secretion regulation by
human AT as whole, 6 genes (based on the gene ontology (http://
www.expasy.org/)) of which 4 genes positively involved in the insulin
secretion and two of them PCSK1 (Proprotein convertase 1 (PC1))
and GCG (glucagon) (Figure 2 C) involved in the regulation of insu-
lin synthesis were measured in pancreas and AT with and without
T2D. GPLD1, CD38 and NNATmRNAs were not expressed or close
to threshold in pancreas tissues with and without T2D, while the
same genes were highly expressed in AT-T2D as compared to AT-
control (Figure 5 D). On the contrary, CAPN10 was up-regulated in
pancreas T2D and down-regulated in AT-T2D as compared with
control tissues (Figure 5 D). PCSK1 as key enzyme involved in bio-
synthesis of insulin was diminished in AT-T2D as compared to
AT-control. However, PCSK1 expression remained unchanged in
pancreas in either state (Figure 5 D).
We hypothesized that insulin protein concentrations are posi-
tively correlated with body fat mass. To test whether the suggested
hypothesis is true, blood insulin concentrations were measured in 41
human subjects. Interestingly, plasma insulin levels were signifi-
cantly higher in three groups of obese subjects (1-Obese, 2-Obese
with T2D and 3-Obese with T2D and insulin injection) than lean
subjects (Figure 6 A). Also, plasma insulin concentrations signifi-
cantly correlated with fat mass (p , 0.00003, r 5 0.6, One way
ANOVA) (Figure 6 B).
To confirm our hypothesis, bariatric surgery was applied to treat
five human obese (BMI above 35) subjects with T2D. After bariatric
surgery, the BMI was tremendously reduced in all subjects from 36–
47 to 26–33 kg/m2 in obese subjects with T2D and rescued these
patients from insulin injection (T2D) (Figure 6 C). The BMI of three
human subjects were reduced to even below 30 (one subject just
www.nature.com/scientificreports
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above 25; lean value). The BMI of the other two patients were con-
tinually reduced by approximately 30%. A weight loss of 40–60 kg
was observed in all subjects.
To establish the assumption that the production of insulin by
human adipocytes is independent of pancreas and provide direct
evidence for adipocyte insulin production in a physiological context,
we measured INS mRNA and insulin protein in pancreas and AT
derived from prediabetic BB (Bio-Breeding) rats (type 1 diabetes 5
T1D-like model). As depicted in figure 7 D and G (in Figure 7 D–G),
IFCSLM analysis of rat-derived pancreas tissue cryostats revealed
that islets of Langerhans-associated b-cells were destroyed and not
detectable in the rats with Insulin Dependent Diabetes Mellitus
(IDDM). This finding is in agreement with all other studies, where
b-cells were destructed in these rats and not present or detectable.
Figure 1 | (A–E). Differentiation of human visceral preadipocytes to adipocytes. (Panel A) shows human pre-adipocytes (no lipid droplets) and
(Panel B) exhibits adipocytes (with medium-sized or single large lipid droplets). In panel A, nuclei and lipid droplets were stained with DAPI and FITC
respectively. Nuclei were indicated by white arrow. In panel B, lipid droplets were stained with FITC and indicated by orange arrow. Almost the whole
space of adipocytes is occupied by lipid droplets. Immune fluorescent confocal laser scan microscopy (IFCLSM) was applied to detect DAPI and FITC.
(Panel C and D) display 5 differentiation marker genes for human primary visceral and subcutaneous adipocytes respectively. mRNA expression was
expressed as2log (for example: the difference between human subcutaneous preadipocytes and adipocytes regarding leptin (LEP) expression is
approximately 7, thus true difference is 27 (5128-fold) and was shown in y-as. Diacylglycerol O-acyltransferase 2 (DGAT2), hormone-sensitive lipase
(LIPE), lipoprotein lipase (LPL) and fat specific protein-27 (FSP27). (Panel E) shows marker gene for human primary visceral and subcutaneous
preadipocytes. Adipocyte enhancer-binding protein 1 (AEBP-1) was higher in human preadipocytes than human adipocytes.
www.nature.com/scientificreports
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Figure 2 | (A–B). mRNA expression analysis of insulin (INS) in human primary subcutaneous and visceral preadipocytes and adipocytes. Relative Insulin
mRNA levels expressed as2log in (Panel A) and as relative intensity in (panel B). mRNA chip (human gene chip) approach was used to detect insulin mRNA
expression. Each sample was measured 4 times by mRNA expression assay (human gene chip). (Panel C). mRNA expression of insulin and glucagon in human
pancreas and adipose tissue (AT) with and without type 2 diabetes (T2D). The mRNA expression levels of insulin and almost glucagon remained unchanged in
pancreas of either state. The mRNA expression of insulin was decreased and glucagon demolished in AT-T2D as compared to AT without T2D.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8816 | DOI: 10.1038/srep08816 4
However, islets of Langerhans-associated b-cells were easily detected
in control rats by using insulin-specific antibodies and Alexa 633 as
detection antibody, as shown in figure 7 L and N. These results were
confirmed by showing that glucagon is present and produced by a-
cells in islets of Langerhans of rat-derived pancreas tissue as depicted
in figure 7 (D-K). We did not observe any signals resulted from IgG
(control) or detection antibody (alexa 633) as displayed in figure 7 A.
As shown in figure 7 H, four b-cells were detected. This confirmed
that almost all islets of Langerhans-associated b-cells were destroyed
and also proves that our strategy is specific and works. Although
IDDM rats, which do not have b-cells and as a consequence there
is no insulin production, AT of both IDDM and control rats produce
clearly and convincingly insulin (Figure 5 A and C, D and F, SI), and
this insulin production is independent of pancreas-associated islets
of Langerhans b-cells. Notably, the staining of insulin in AT of
IDDM was much stronger than insulin staining in the AT of control
rats (Figure 5, SI).
To confirm the data obtained by IFCLSM analysis of pancreas
cryostats and AT, the total RNAs were collected from the same
tissues derived from the same rats for mRNA analysis (QPCR).
Since the rats have two insulin genes, Ins1 (P01325) and Ins2
(P01326), both Ins1 and Ins2 mRNAs were also measured in pan-
creas and AT. The relative intensity of mRNA Ins1 and Ins2 were the
highest in the AT and lowest in pancreas tissues of IDDM rats as
depicted in figure 8 A-B. Surprisingly and unexpectedly in IDDM
rats, which have no or very low number of b-cells, the mRNA
expression of Ins1 is very high in the AT of IDDM rats (Figure 8
A), whereas control rats, which appeared to have enough b-cells, the
mRNA expression of Ins1 is low in the AT of control rats. We did
perform this experiment for Ins2 too (Figure 8 B).
Since human adipocytes are a source of insulin production, we
sought to investigate if other human primary cell types express insu-
lin. Thus, we examined 6 other human primary cell types (plus 4
subcutaneous and visceral (preadipocytes and adipocytes) from two
new biological variant) as well as one cell line (Podocytes) for insulin
production (Figure 8 C). Notably, as depicted in figure 8 C, insulin
was expressed by almost all cells used in this study. Although the INS
gene expression is very high in pancreas b-cells and it is not com-
parable with the expression of insulin by other cell types and AT, the
other cells are able to express insulin.
To check whether INS gene expression is biologically active, all
cells were treated with LPS. Upon the LPS treatment, INS mRNA
expression increased or decreased as compared to the cells without
LPS treatment such as visceral preadipocytes and visceral preadipo-
cytes plus LPS (Figure 8 C).
Discussion
This study was designed to unravel the role of adipocytes behind the
link between obesity and insulin regulation in human. The purity and
specificity of preadipocytes and adipocytes fractions were established
using two independent techniques: IFCLSM and 6 preadipocytes/
adipocytes gene markers. The mRNA expression data convincingly
showed the expression of INS gene in all 16 measurements (preadi-
pocytes and adipocytes of both subcutaneous and visceral cells, first
Figure 3 | (A–F). Immunofluorescent confocal laser scanning microscopy (IFCLSM) analysis of human visceral adipocytes. From A to F, confocal
microscopy analysis was applied to detect and localize insulin protein in the human primary visceral adipocytes. The cultured adipocytes in six-well plates
were incubated with IgG1 isotype and the detection antibody Alexa 647 (A; considered as negative control), lipid droplets were visualized with FITC (B;
green color); adipocyte was incubated with monoclonal antibody against human insulin (C, red color). Bound antibodies were detected with Alexa 647
coupled goat anti-mouse (C; red color); adipocytes were stained with DAPI to detect nuclei (D, blue color), C (insulin) and D (nuclei) were merged (E),
and B (lipid droplets), C (insulin) and D (nuclei) exhibit a merge of all three labeling (F). Insulin protein was located on the surface of plasmamembrane
and cytoplasm (C, E and F) of human visceral adipocytes. Fluorescent labeling was used for all detections. Originalmagnification was 400 times. The same
results were found for human subcutaneous adipocytes (Figure 2 A–G, SI).
www.nature.com/scientificreports
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experiment). Notably, an intense insulin protein staining was pre-
sent in cytoplasm and plasma membrane of human visceral and
subcutaneous adipocytes, but not in human preadipocytes, and
that is due to the presence of large lipid droplets (fat storage
depot) within adipocytes. Also, these data were confirmed by
IEM and IFCSLM. Last but not least, we observed the secretion
of insulin by both human adipocytes (subcutaneous and visceral)
and no insulin secretion by both human preadipocytes (subcutan-
eous and visceral). Hence, it seems reasonable to conclude that we
could not detect insulin in human preadipocytes-secreted frac-
tions because of the absence of lipid droplets (energy storage
depot). Although Gerozissis14 and Kojima et al.15 suggested the
extrapancreatic insulin production; our data confirmed not only
the concept suggested by Kojima et al. but also the insulin pro-
duction by adipocytes and other cells in normal state and mech-
anism behind that. Although insulin is similar to insulin-growth
factor 1 and 2 (IGF-1 and IGF2) in sequence and structure, which
lays out the ground of cross-reactivity of INS mRNA with that of
IGF1 and IGF2, the selected probe sequence for IGF1 and IGF2
genes was different from insulin probe sequence (only approxi-
mately 25–28% sequence homology between these two probes and
Insulin). This indicates that insulin probe is specific for insulin
gene and do not react with IGF1 and IGF2. Also the pattern
expression of these three genes are completely different in pan-
creas and AT in either state, confirming that there is no cross-
reactivity between these three mRNAs.
Insulin secretion was reduced upon treatment of human adipo-
cytes with LPS or glucose. Based on published data, both LPS and
glucose16–19 induce inflammation, which in turn results in an
increased lipolysis20–22. As a consequence, fat mass homeostasis
would be disrupted and in line with our initial observations, no
insulin secretion by human preadipocytes (lacking lipid droplets)
would occur. Consistently, the results obtained by visceral adipocytes
treated with glucose showed almost the same pattern as b-cells
treated with glucose in vitro23. Since the stimulation of cells with
glucose results in an inflammatory state similar to the effect of
LPS, and this similarity extends to insulin levels, and given that IL-
6 and IL-816 were clearly and convincingly expressed by human pre-
adipocytes, the absence of insulin secretion by human preadipocytes
is a specific phenomenon and therefore human preadipocytes can be
considered as a good negative cell control. The reason why we have
chosen to measure IL-6 and IL-816 is that these cytokines have
already been established to be secreted by human preadipocytes.
Notably, since other cells express insulin exceptmonocytes, the other
cells can be considered as positive control. Since monocytes are
circulating cells, it is reasonable to assume that monocytes do not
express insulin.
We found that human primary adipocytes constitutively produce
and release very low but not trivial amounts of insulin. This intri-
guing discovery helps us to reshape thinking that explains how obes-
ity could increase the risk for developing T2D.
Since blood insulin levels were high in all human obese subjects as
compared to lean subjects and showed a highly significant positive
correlation, our suggested hypothesis that blood insulin concentra-
tions increase with the increase of body fat mass is indeed true. It is
then possible to suggest that insulin production by obese AT
increases the risk for T2D. This positive correlation appears to be
in apparent agreement with our in ex-vivo observations where we
Figure 4 | (A–E). Confocal microscopy analysis was applied to detect and localize insulin protein in the human primary visceral preadipocytes. The
cultured preadipocytes in six-well plates were incubated with IgG1 isotype and the detection antibody Alexa 647 (A; considered as negative control), lipid
droplets were stained with FITC (B; green color); adipocyte was incubated with monoclonal antibody against human insulin. Bound antibodies were
detected with Alexa 647 coupled goat anti-mouse (C; red color); preadipocytes were stainedwithDAPI to detect nuclei (D, blue color). E (merge) exhibits
a merge of all three labeling; B (lipid droplets), C (insulin) and D (nuclei). Insulin protein was located in cytoplasm and on the surface of plasma
membrane (C and E) of human visceral preadipocytes. Fluorescent labeling was used for all detections. Original magnification used was 400 times. The
same results were found for human subcutaneous preadipocytes (Figure 3 A–G, SI).
www.nature.com/scientificreports
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were unable to detect insulin protein by human primary preadipo-
cytes (no lipid droplets). Finally, it must be stressed that our hypo-
thesis regarding insulin and lipid droplets was also confirmed by in
vivo studies by Puri et al.24–27. These authors have shown that FSP27
protein promotes energy reservoir in the form of TGs within lipid
droplets and knock out of Fsp27 gene in mice led to the increase of
lipolysis, protecting mice from diet-induced obesity and IR. Since i)
the expression of three genes (GPLD1, CD38 and NNAT) with a vital
role in the positive regulation of insulin secretion are absent in pan-
creas, but highly up-regulated in AT-T2D, ii) the expression of
CAPN10 gene (with same function as other three genes) was highly
up-regulated in pancreas-T2D, but completely diminished in AT-
T2D, iii) the expression of PCSK1 (vital enzyme in proinsulin
conversion) is highly expressed in pancreas in either state, but
demolished in AT-T2D, and iv) the same pattern was observed for
GCG, it is reasonable to postulate that pancreas and AT ‘‘talk’’ with
each other to ensure a homeostatic energy metabolic system in nor-
mal state or minimize the damage in a diabetic state.
A reduction of fat mass was found in 5 patients with T2D after
bariatric surgery. Intriguingly, the fat loss rescued and repaired these
human subjects from T2D, ensuring ‘‘a great feel of freedom and
relief’’. These data indicate that fat loss in these subjects potentially
resulted in a reduction of insulin production by AT, which in turn
restore the insulin ability of pancreas-associated b-cells to adjust
blood glucose without external insulin injection, confirming our
above suggested hypothesis that high concentration of insulin by
obese AT deteriorates the insulin function by pancreas b cells. This
finding suggests a direct physiological role of insulin produced by
AT. However, this hypothesis remained to be in-depth elucidated.
Since INS mRNA and protein expression were tremendously
higher in AT-T1D-like rats than control rats, these results provide
a direct evidence for physiological role of AT-insulin production.
Also, the INS mRNA expression was decreased in AT-T2D as com-
pared to control subject, while the INSmRNA expression in human
Figure 5 | (A–B). ELISA Analysis of insulin in secreted fraction collected
from human primary preadipocytes and adipocytes. ELISA analysis of
secreted fractions collected from with and without lipopolysaccharides
(LPS (200 ng/ml)) and 25 mM glucose treated human primary visceral
and subcutaneous preadipocytes and adipocytes. DAKO insulin ELISA kit
was applied to measure insulin concentrations in the secreted fractions.
Two independent ELISA was used to measure insulin concentrations in
secreted fractions; insulin concentration in secreted samples was
performed respectively in single and duplicate by ELISA. Insulin
concentrations were expressed in pg/ml as shown in Y-axis.
(panel A); visceral cells and (Panel B). subcutaneous cells. The p-value
obtained from an independent two-tailed test samples (T-Test). P, 0.05
was accepted as statistically significant. (Panel C). IL-6, IL-8 and M-CSF
analysis in human primary subcutaneous preadipocytes. IL-6, IL-8 andM-
CSF were measured in human primary subcutaneous preadipocytes, using
Bio-plex according to instructions provided by Bio-Legend. Red bars
represent human preadipocytes without LPS treatment and dark blue bars
show human preadipocytes treated with LPS. The concentrations of these
three cytokine and chemokines were expressed as pg/ml shown in Y-axis.
Samples were measured in duplicate. (Panel D). mRNA analysis of genes
involved in positive regulation of insulin secretion, glucose induced insulin
stimulation in pancreas, and biosynthesis of insulin. GPLD1, CD38,
NNAT, CAPN10 and PCSK1 genes were measured in human pancreas and
AT with and without T2D. The first four genes are involved in positive
regulation of insulin secretion and PCSK1 is involved in biosynthesis of
insulin via proinsulin conversion. Glucagon (GCG) was depicted in
Figure 2 C. mRNA expression expressed as2log. Each sample wasmeasured
two or three times by mRNA expression assay for pancreas and AT
respectively.
www.nature.com/scientificreports
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pancreas (saturated state) remained equal between control and pan-
creas-T2D.
Of note, the expression of insulin was observed in different human
primary cell types and that makes us to re-design our investigations
related to insulin and its linkage with diabetes in future studies.
The results presented in this study indicate that the constitutive
synthesis of insulin by adipocytes and other cells apparently
smoothen the dynamic regulation of insulin levels by the b-cells of
the endocrine pancreas and thus provide a plausiblemechanism as to
how obesity (fat mass) could potentially cause insulin resistance. AT
may be also considered as compensate endocrine organ for energy
metabolic disorders. Lipid droplets show a link with the regulation of
insulin synthesis in human adipocytes.
This study provides a novel knowledge about the role of adipocytes
in human insulin regulation and opens a new avenue towards the
therapy of T2D in the future.
Methods
Four different models were used. The description of methods is given in this section.
In vivo (five different groups of human subjects). 41 human subjects divided into
four groups of 10 (except diabetes group receiving insulin containing 11 subjects),
independent of age and gender, as follows: Group 1-Lean subjects with a body mass
index (BMI) between 20.1 and 25.6, Group 2-Obese subjects with a BMI above 30,
Group 3- Obese subjects with T2D without receiving insulin and a BMI above 30 and
Group 4- Obese subjects with T2D, receiving insulin and BMI above 30. All patients
were well-matched for their BMI. It must also be stressed that in lean group only one
person has a BMI above 25 (BMI 5 25.6). A fifth group of human subjects includes
five human subjects with T2D and a BMI of over 35 but independent of age and
gender were used to measure blood insulin and BMI after obesity surgery.
Ex Vivo (Human Primary cell types). 10 human primary cell types28, one human
immortalized cell line (Podocytes) was kindly provided by professor M.A. saleem29,
were used in this study. These human primary cells are: 1-PoieticsTM visceral
preadipocytes (LONZA, USA/Belgium), 2-adipocytes (preadipocytes differentiated
to adipocytes), 3-subcutaneous preadipocytes (LONZA, USA/Belgium), 4-
subcutaneous adipocytes (preadipocytes differentiated to adipocytes) 5-bonemarrow
derived human primary mesenchymal stem cells (hMSC-BM) (PromoCell,
Germany), 6-dermal fibroblasts (PromoCell, Germany), 7-umbilical vein endothelial
cells (HUVECs) (University Medical Center Groningen (UMCG) endothelial
Facility), 8-peripheral blood CD141 monocytes (LONZA, USA/Belgium), 9-
macrophages (monocytes differentiated to macrophages by phorbol-12-myristate-
13-acetate (PMA), and 10-hepatocytes (Becton & Dickinson (BD) USA/Germany).
Human primary preadipocytes were differentiated into adipocytes as described by
Meijer et al.30 and the instructions of PromoCell Company. To this end (first
experiments), stringent criteria were applied to prevent or suppress the false positive
and artifact results in the human primary subcutaneous and visceral (preadipocytes
and adipocytes). Human primary subcutaneous and visceral (preadipocytes and
adipocytes) RNAs were isolated from two independent technical replicates and each
Figure 6 | (Panel A). DAKO insulin ELISA kit was applied to measure
insulin concentrations in the plasma of 41 human subjects categorized in
four groups based on Body Mass Index (BMI); 1- Lean subjects (BMI,
20.1–25.6, only one patient above 25), 2- Obese subjects (BMI, 32.5–39.5),
3-Obese subjects with type 2 diabetes (T2D) without receiving insulin
(BMI, 32.1–40) and obese subjects with T2D, receiving insulin (BMI, 33.3–
38). BMI is expressed as mass (kg)/(height (m))2. The p-value resulted
from one-way analysis of variance (ANOVA). P , 0.05 was accepted as
statistically significant. Insulin concentrations were expressed as pmol/l
shown in Y-axis. (Panel B). Correlation between plasma insulin
concentrations (n5 41 human subjects) and BodyMass Index (BMI). BMI
is expressed asmass (kg)/(height (m))2. The p-value resulted fromone-way
analysis of variance (ANOVA). P , 0.05 was accepted as statistically
significant. Insulin concentrations were expressed as pmol/l shown in Y-as
and BMI was expressed as2log shown in X-axis. There was a strong positive
correlation between plasma insulin concentration and human BMI (P ,
0.00003, r5 0.6). (Panel C). The bariatric surgery of 5 human subjects with
type 2 diabetes. The BMI (fat reduction) was measured three times in 5
patients; 1- before bariatric surgery is considered as basis point, 2- after
surgery (depends on the date of surgery) and 3- the lastmeasurement point
(6months after the secondmeasurement). BMIwas sharply decreased after
the surgery. The BMI was calculated as Kg/m2 shown in Y-axis. The time
point 0 is considered as before surgery. The X-axis shows the BMI
measurements in different time points.
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replicate was performed in duplicate and each sample wasmeasured in human chip in
duplicate. Finally, each cell type was measured four times (in total 16 times). Also, the
gene expression was expressed as2log to suppress false positive results derived from
intrachip comparison as well as the up-regulation and down-regulation of genes are
treated in a similar fashion31.
Preadipocytes and adipocytes markers. Five mRNA markers of both visceral and
subcutaneous adipocytes, (i.e. Diacylglycerol O-acyltransferase 2 (DGAT2; accession
number Q96PD7), leptin (LEP; P41159), hormone-sensitive lipase (LIPE; Q05469),
lipoprotein lipase (LPL; P06858) and fat specific protein-27 (FSP27;
Q96AQ7)24–27,32,33 (Figure 1 C–D) and one preadipocytes marker; adipocyte
enhancer-binding protein 1 (AEBP-1; Q8IUX7) were measured34.
Genes involved in positive regulation of insulin secretion, glucose induced insulin
stimulation in pancreas, and biosynthesis of insulin. The expression of Six genes
were measured in human pancreas and AT with and without T2D. GPLD1
(P80108)35, ADP-ribosyl cyclase 1 (CD38; P28907)36, Neurontin (NNAT; Q16517)37,
and Calcium-activated neutral proteinase 10 (CAPN10; Q9HC96)38 were involved in
positive regulation of insulin secretion. Glucagon (GCG; P01275)39 was involved in
glucose induced insulin stimulation. Proprotein convertase 1 (PSCK1; P29120)40 was
considered as key enzyme in biosynthesis of insulin via conversion of proinsulin.
Last but not least, Insulin (INS; P01308) itself was measured. The selection of these
genes was based on gene ontology and WWW.expasy.org was applied (Swiss
proteomics).
In Vivo (Human pancreas and Adipose tissues). Human pancreas tissues (control
and T2D), and AT (control and T2D) were purchased from AMS Biotechnology
(AmsBio, England). INS mRNA expression was measured in these tissues. Probe
sequence for human INS gene is: ACCCGCCGCCTCCTGCACCGAGAGAG-
ATGGAATAAAGCCCTTGAACCAGC and for human IGF1 (insulin-like growth
factor 1) gene is: GAGGCCCAGGGGATTTTTGAAGCTGTCTTTATTC-
TGCCCCCATCCCAACC. and for human IGF2 (insulin-like growth factor 2) gene
is: AGGGAGGCCAAACGTCACCGTCCCCTGATTGCTCTACCCACCCAAG-
ACCC.
Figure 7 | (A–N). The localization and visualization of Insulin and Glucagon in the pancreas tissue cryostats of prediabetes BB rats (T1D-like model)
using confocal microscopy strategy. Confocal microscopy analysis was used to localize Insulin and Glucagon in insulin dependent diabetes mellitus
(IDDM) and control rats. The glucose concentration of control rats were between 14 and 16 mmol/l. The glucose concentration in IDDM rats were
between 28–30 mmol/l. Cryostats weremade frompancreas tissues of these rats. The thickness of pancreas cryostats was 5mm.A cryostat slide was stained
only with IgG isotype and alexa 633 coupled goat anti-guinea pig (panel A); considered as a negative control). This slide was not incubated with primary
polyclonal antibody. The nuclei were stained with DAPI. Other cryostats were also stained with Polyclonal antibody against rat insulin and bound
antibodies were displayedwith alexa 633 coupled goat anti-guinea pig (panel D andG;H andK; L andN; red color). Other cryostats were also stainedwith
Polyclonal antibody against rat glucagon and bound antibodies were displayed with alexa 488 coupled goat anti-rabbit (panel E and G; I and K; green
color). DAPI was used to stain and detect nuclei in all tissues; F and G; J and L; N and O; dark blue color. Fluorescent labeling was used for all detections.
Insulin was not detected in IDDM rats but glucagon (green fluorescent) well. Insulin was found to be positive in islets of Langerhans-associated b cells in
control rats. In an islet of Langerhans, four b cells were found to be positive for insulin as indicated by 4 light yellow arrows. Glucagon as positive control
was found to be positive in the pancreas-associated islets of Langerhans b cells in both IDDM and control rats.
www.nature.com/scientificreports
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All experiments were performed according to the manual instructions provided by
the companies. These three probes were used for all screening of Insulin, IGF1, and
IGF2 in pancreas, AT, and preadipocytes and adipocytes and all other cell types used
in this study.
The specific monoclonal antibody against human insulin combined with
Transmission Electron Microscopy (TEM) and/or confocal microscopy were used to
visualize insulin protein in human adipocye slides.
InVivo (prediabetes BB rat pancreas andAdipose tissues). Prediabetes BB rats were
chosen as model in study because we must have a model that islets of Langerhans-
associated b-cells are selectively destroyed or not functional T1D-like model). Based
on search machine, prediabetic BB (Bio-Breeding) rats are considered as a good and
established model for studying insulin-producing b-cell destruction located in the
islets of Langerhans in pancreas during the development of Insulin Dependent
Diabetes Mellitus (IDDM)41–43. For this reason, we have chosen for prediabetes BB
rats. Total RNAs were collected from prediabetes BB rats (IDDM and control rats
were kindly provided by Dr. Visser (‘‘Animal care and handling was in agreement
with NIH protocol for animal treatment (NIH publication no. 85–23; revised 1985),
and animal experiments were approved by UMCG Ethical Board for Animal
Studies’’)44,45. The methods were carried out in "accordance" with the approved
guidelines. The glucose concentration was used to monitor rats with IDDM (glucose
concentration 28–30 mmol/l) and control (glucose concentration 14–16 mmol/l)
rats. Total RNAswere collected frompancreas and adipose tissues tomake cDNAs for
QPCR. The KAPA SYBRH FAST qPCR Kit (Sopachem) was used for QPCR. Total
volume for QPCRwas 20 ml. Since the rodents have two insulin genes (Ins1 and Ins2),
the relative intensity of both Ins1 and Ins2 were measured. Insulin mRNA levels are
expressed relative to b-actin mRNA levels. All primers46 were HPLC purified. Primer
sequences are as follows:
Rat Ins1 and Ins2 forward primers: GCCCAGGCTTTTGTCAAACA
Rat Ins1 reverse primer: GTTCCCCACACACCAGGTAGAGAG
Rat Ins2 reverse primer: CTCCCCACACACCAGGTAGAG
Rat b-actin forward primer: ACGAGGCCCAGAGCAAGA
Rat b-actin reverse primer: TTGGTTACAATGCCGTGTTCA
Experiments. Total RNAs were isolated from human primary cells (Human genome
Chip), human ((Human genome Chip) and prediabetes BB rats tissues to use in
mRNA expression analysis, applying Nucleospin kit. All experiments were executed
according to the instructions provided by Nucleospin. The specific monoclonal
antibody against human insulin, rat insulin, and rat glucagon combined with
Transmission Electron Microscopy (TEM) and/or confocal microscopy or
Immunoelectron microscopy were used to visualize insulin protein in human
adipocyes slides. Multi-plex ELISA of IL-6, IL-8 andM-CSF proteins were purchased
from Biolegend and the experiments were performed according to the Biolegend
instructions.
Before the collection of media for secretion analysis, all media with supplement
were withdrawn and the cells were washed 5 times with the differentiation media
(without supplement). After wash steps, the cells were incubated with the differ-
entiation medium (without supplement or any other additional components such as
antibiotic and phenol red) for 2 days (48 h) and medium collected containing
secretion proteins of human preadipocytes/adipocytes. The final media, which was
used for incubation of cells for all experiments were blank (contains no supplements,
insulin, phenol red, and antibiotica).
The collected media were subsequently concentrated, using a cut-off filter of
3 kDa. This collected media were used for further experiments. The remained cells
were also used for imaging.
Figure 8 | (panel A–B). mRNA expression analysis of insulin1 and insulin2
in prediabetes BB rats (T1D-like). (A), mRNA expression of insulin1 (Ins1)
and (B), insulin2 (Ins2) were measured in pancreas and adipose tissues of
IDDM and control rats, using QPCR with Taqman 7900HT. Relative
intensity of mRNA was expressed as (DDCt). The amount of the gene of
interest (Ins1 and Ins2 were normalized to b-actin as endogenous reference
and relative to a control sample is 2exp-DDCt. The DDCt is DCt ‘‘treated’’ -
DCt control. AT-control was considered as DCt control and tissues with
T1D-like were considered as DCt treated. After corrections, AT-control was
adjusted to 1. Two independent biological replicates were used in mRNA
expression analysis. The p-value obtained from an independent two-tailed
test samples (T-Test). P , 0.05 was accepted as statistically significant.
(Panel C). Expression of insulin by 10 human primary cell types: stem cells,
fibroblasts, endothelial cells, macrophages, preadipocytes (Visceral and
Subcutaneous; other biological variant) and adipocytes (Visceral and
Subcutaneous; other biological variant), hepatocytes, monocytes and one
cell line (podocytes). All cells were studied with and without exposure to
LPS. mRNA expression of insulin was determined in 11 different human cell
types, of which preadipocytes and adipocytes (visceral and subcutaneous)
were new biological samples, treated with or without LPS. The level of each
mRNA was measured in triplicate (except podocytes) and error bars show
standard deviations of means for triplicate cultures per condition and is
represented as the mean 6 SEM. The p-value obtained from a paired t-test
with a two-tailed test samples (T-test). P , 0.05 is considered statistically
significant. Insulin mRNA expression is expressed as2log values on the Y-
axis. Insulin mRNA expression was detected in all cells tested (except traces
for monocytes). Relative mRNA intensity was performed triplicat.
www.nature.com/scientificreports
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DAKO insulin ELISA kit was applied to measure insulin concentrations in the
secreted fractions.
According to DAKO insulin ELISA kit information and instruction, cross react-
ivity with ‘‘C-peptide at a concentration of 5000 pmol/L was below the detection limit
of the insulin assay’’. The Dako Insulin assaymeasures biologically active insulin with
a high degree of specificity. All human primary cells were treated with 200 ng/ml
lipopolysaccharides (LPS). All collected human preadipocytes- and adipocytes-
secreted fractions were already treated with 200 ng/ml LPS or 25 mM glucose, for all
human mRNA analyses.
Ethics statement. This study was approved by the Medical Ethical Committee of the
Erasmus Medical Center, Medical University of Rotterdam, under MEC number:
2009-242.Written informed consent was obtained from all participants. Themethods
were carried out in ‘‘accordance’’ with the approved guidelines.
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